GRA Notes - Archives
- New video spotlights UGA Scholar’s pursuit of universal vaccine
- Treatment for dry eye to advance in study following $5M investment in Cambium
- Newly christened institute at Georgia State prepares tomorrow's creative thinkers
- NeurOp will test drug to prevent ischemia
- Scholarly gathering forges new connections
- Bio industry convenes, and GRA is all around
- In appreciation of our partner in flight: Delta
- GRA-backed alliance gets $51M HIH grant, welcomes UGA
- Acquisition of tech startup Vertera Spine illustrates the potential of GRA Ventures
- National effort shaped by Georgia Tech, GRA advances with $20 million grant from NSF
- Tracking vehicle fleets is just the beginning: Investors see great potential in Cognosos
- $11M grant to expand Emory autism research
- FDA: Thumbs up to finger-prick anemia test
- A new era of drug discovery dawns at UGA
- GRA named 'unsung hero' of collaboration
- Gifts from the gifted (and thanks from us)Nano-biotech expert arrives at GA Tech as GRA Eminent Scholar
- UGA startup forges different path in learning
- Transforming the transformers: Georgia Tech aims to usher in a new era of power delivery
- Join the discussion: The future of water tech
- GRA Trustees among 'most respected' CEOs
- Gifts from the gifted (and thanks from us)
- Carbice nets $1.5M investment, co-led by GRA Venture Fund
- Inlighta lands $2M grant to test MRI agent
- Eye-tracking study: How children focus on the world can be traced to genetics
- Nothing like experience: Georgia Tech's VIP helps prepare the workforce of tomorrow
- GRA welcomes (and thanks!) Wells Fargo
- GRA Venture Fund adds FraudScope to its portfolio
- Clinical trial validates vaccination patch invented by Georgia Tech
- Peanut genome expert to remain at University of Georgia
- Georgia's research prowess wins national recognition
- GRA's commercialization program nabs national prize
- Cooper, Ahmed celebrated for historic contributions to science
- Que Oncology gets $16M investment
- Susan S. Margulies coming to Georgia as GRA Eminent Scholar
- Emory's Winship Cancer Institute receives NCI designation
- UGA joins ranks of commercialization elite with NSF I-Corps site
- Augusta University scientists identify protein's potential to fight cancer
- GRA Eminent Scholar to advise NIH director
- NIH renews funding for Emory AIDS research
UGA spotlights value of GRA partnership, Eminent Scholars
- UGA spotlights value of GRA partnership, Eminent Scholars
- New NIH-funded research at Georgia State will explore diabetes-related heart condition
- One to watch: Young Georgia Tech scientist captures attention — and $1M — from NSF
- Emory: Testing for activated T cell in patients with lung cancer may predict shrinking tumor
- 'Sugar scientists' gather at state symposium
UT neuroscientist moving research to Augusta University
- UT neuroscientist moving research to Augusta University
- New investment powers Urjanet expansion
- GRA Eminent Scholar targets Ebola virus
- Emory discovery helps clarify how to make some cancer-fighting drugs more effective
- WSB-TV program spotlights GRA's impact
- SE Conference selects GRA Eminent Scholar for 2017 Faculty Achievement Award
- Looking for inspiration for innovation? Make plans to come to Rome, Ga. April 13-14
Video showcases Georgia States ascent in biomed research
- Video showcases Georgia State’s ascent in biomed research
- University of Georgia joins consortium working to reduce risk, cost of cell therapies
- Georgia universities team up to speed ‘translation’ of diabetes research
- 'Spider web' approach developed at Emory may open the door to new cancer drugs
- Georgia Tech startup is featured in GA Trend
- GRA welcomes aboard Delta Air Lines
- What will make you sick when you’re older? New study aims to predict potential threats
Analysis: Group of Eminent Scholars made major impact
- Analysis: Group of Eminent Scholars made major impact
- Spinal fusion innovator Vertera continues its rapid rise with GRA Ventures' support
- UGA startup's unique 'far red' lighting system makes indoor agriculture more viable
- GRA has high profile at annual industry event
- Magazine spotlights pioneering work of GRA Eminent Scholar 40 years ago
- Discovery: Gene produces schizophrenic-like symptoms after mutations in mice
UGA recruits expert on infectious disease as GRA Eminent Scholar
One of the world’s leading experts on malaria and parasitic diseases is GRA’s newest Eminent Scholar. Recruited from the University of South Florida, Dennis Kyle joins the University of Georgia on January 3.
Magazine: Georgia's bioscience industry is gathering momentum
Research labs at Georgia’s universities — and the startups they spawn — are an integral part of the state’s $15 billion bioscience landscape, Georgia Trend magazine reports this month. The feature article “Under the Microscope” examines assets such as nationally recognized research centers and strong collaboration that have led Georgia to an enviable position in bioscience.
Georgia Tech's Rohatgi to build on solar-cell success
GRA Eminent Scholar Dr. Ajeet Rohatgi of Georgia Tech has repeatedly broken records for engineering high-efficiency cells that can be produced faster and at lower cost. A new 2-minute GRA “Breakthrough” video, airing on WPBA-TV, traces the arc of Rohatgi’s pioneering work in the field. • Watch the video >
Infectious disease expert joins UGA as a GRA Eminent Scholar
The scientist who discovered a protein element key to a vaccine against a deadly lung infection is the newest GRA Eminent Scholar. Karen Norris, who starts at the University of Georgia on September 1, is regarded as one of the nation’s leading researchers in infectious diseases.
A new video airing on Atlanta's PBA 30 recounts the 1960s breakthrough made by GRA Eminent Scholar Max Cooper that changed the prevailing view of the human immune system.
Georgia leads national effort to standardize manufacture of cells
As therapies based on human cells continue to evolve in modern medicine, a need to bring consistency to how such cells are mass-produced has emerged. Now, a national consortium led by GRA and Georgia Tech has completed a road map to create such standards and make the U.S. a world leader in cell therapy manufacturing. Announced this month at the White House, the 10-year national road map reflects the input of 60-plus representatives from industry, government and nonprofit organizations.
Georgia State recruits top Ebola researcher
Georgia’s newest GRA Eminent Scholar is a leading expert on Ebola and other emerging viruses. Chris Basler, who joins Georgia State University from New York’s Icahn School of Medicine, is program director on two NIH grants and principal investigator on a third — all totaling $20 million through 2019.
NIH re-invests in work of Clark Atlanta center
Prostate cancer research at Clark Atlanta University got a major boost in April with news of $2.75 million in NIH grants to a research enterprise headed by GRA Eminent Scholar Shafiq Khan.
GRA Ventures companies net $1 billion in equity investment
Companies launched out of Georgia's universities with early-stage investment from GRA Ventures reached a major milestone in March: A collective total of $1 billion in additional equity investment from venture capital firms and other investors.
Universities explore ways to combat the Zika virus
Even before the World Health Organization formally declared the Zika virus an international health emergency on Feb. 16, scientists at Georgia’s universities were at work investigating ways to prevent and treat the virus.
It’s well known that GRA’s strategic investments in talent and infrastructure help Georgia’s universities secure major federal research grants. But this leverage also applies to private funding sources, as evidenced by two philanthropic gifts announced this month to strengthen university research.
From research to revenue: New beginnings worth noting
Two different ceremonies this fall illustrated the life cycle of scientific discovery in Georgia — and how it ultimately grows the economy and benefits humankind.
GRA briefs Georgia delegation, honors Sen. Johnny Isakson
A stunning view of the U.S. Capitol from the Jones Day law firm in Washington, DC provided the backdrop to GRA’s briefing this month to the Georgia Congressional delegation on how the state’s research universities are contributing to Georgia’s economic vitality.
Georgia's universities report big gains in research funding
Early numbers this fall show that Georgia's research universities continue to be powerful magnets for attracting external grants to advance scientific exploration.
A record year of recruitment
Georgia became the new research home for eight world-class scientists in FY15 — the largest class of GRA Eminent Scholars recruited to the state's universities in over a decade.
The Scholars, whose research ranges from molecular medicine to energy management technologies, are occupying endowed chairs at Emory, Georgia Tech, Georgia State and The University of Georgia. They arrived with $27 million in federal funding for their research.
Clean Hands Safe Hands secures patents, investment
A technology developed by Clean Hands Safe Hands (CHSH) aims to reduce those infections by promoting hand hygiene in an entirely new way.Headquartered at ATDC, the company got a big boost in July with the awarding of two patents and the approval of a key Phase III investment from GRA Ventures.
Invention grows here: Georgia prominent in top 100 patent list
Poultry vaccines discovered at The University of Georgia. A new device from Emory to treat kidney failure. Technology developed at Georgia Tech to harvest and re-use energy from portable devices.
Trustee meeting brings review of GRA's impact over time
Anniversaries typically bring reflections of the past, but the marking of GRA’s 25th anniversary at the May 21 Board of Trustees meeting was just as much about the organization’s present and future.
Expert in metabolomics named newest GRA Eminent Scholar
A leader in a scientific field that explores how molecules sustain life is joining The University of Georgia as the state’s newest GRA Eminent Scholar.
Varian's Georgia connection runs deep, gets stronger
This month brought the announcement that cancer treatment system manufacturer Varian Medical Systems will make Georgia its East Coast hub — and the news is further testament to the company’s strong relationship with the state’s R&D ecosystem.
Marking a milestone: 25 years
As GRA turns 25 years old this year, the organization remains one of the nation’s most enduring partnerships of business, government and academia. Other states have copied our model since, but none has surpassed GRA’s unity or impact.
New GRA Eminent Scholars coming to UGA in 2015
Two highly acclaimed scientists whose work is influencing treatments for Alzheimer’s and infectious diseases have been recruited to the University of Georgia as the state’s newest GRA Eminent Scholars.
Ted Ross, who directs vaccines and viral immunity research at Florida’s Vaccine and Gene Therapy Institute, brings a track record of translating lab science into promising candidates for vaccines. And Robert Haltiwanger, whose discovery of a cell signaling inhibitor informed a new wave of potential treatments for Alzheimer’s, joins UGA from Stony Brook University.